Since Bub1 inhibitors are under evaluation for their anti-cancer potential [24], for this assay, we compared three different human cell lines: the ovarian cancer cell lines OVCAR-3 and Kuramochi, and the non-transformed cell line RPE1 for comparison. This evidence concerns the gene BUB1 and ovarian carcinoma.